aycan at RSNA 2014 will demonstrate a new integrated RIS/PACS solution.
aycan will highlight at RSNA 2014 its latest vendor-neutral archiving, viewing, printing, and integration solutions and services.
The aycan workflow is a fully integrated RIS/PACS solution that provides a turnkey end-to-end digital imaging and patient management system, aycan said in a release. The system is comprised of aycan’s PACS and medQ’s RIS enterprise technology. The system includes a RIS driven workflow with full order entry and work lists for front office staff and technologists; complete patient histories; linking from the reading work list to the viewer; local cache preloading of image data on the workstation; report dictation options definable by the user (voice recognition and transcription-based); report macros with manual and automatic pre-population options; and fully automated report distribution options.
The aycan OsiriX PRO 3.0 will see new features in its database, viewer, advanced hanging protocols, plug-in, report plug-in, and more, aycan said.
[[{"type":"media","view_mode":"media_crop","fid":"29627","attributes":{"alt":"aycan workflow","class":"media-image media-image-right","id":"media_crop_2273960906927","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"3075","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 215px; width: 441px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":"aycan workflow","typeof":"foaf:Image"}}]]
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the recent RSNA conference.
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.